Literature DB >> 20881758

Elevated levels of tau protein in cerebrospinal fluid of patients with probable Creutzfeldt-Jakob disease.

Gui-Rong Wang1, Chen Gao, Qi Shi, Wei Zhou, Jian-Ming Chen, Chen-Fang Dong, Song Shi, Xin Wang, Yan Wei, Hui-Ying Jiang, Jun Han, Xiao-Ping Dong.   

Abstract

INTRODUCTION: A definitive diagnosis of Creutzfeldt-Jakob disease (CJD) can only be made by neuropathologic examination and demonstration of typical pathologic changes and the pathologic prion protein in central nervous tissues. This study investigated the diagnostic sensitivity and specificity of the microtubule-association protein tau in cerebrospinal fluid (CSF) from Chinese patients with sporadic CJD.
METHODS: Two hundred two CSF samples from clinically suspected patients with sporadic CJD were analyzed for tau protein by enzyme-linked immunosorbent assay and for the signal transduction regulatory protein 14-3-3 protein by immunoblot.
RESULTS: Remarkably increased levels of tau protein and increased incidence of 14-3-3 positivity were observed in probable CJD, when compared with possible CJD and others. With a threshold of 1400 pg/mL, tau determination showed a sensitivity of 90% and a specificity of 94% for the diagnosis of probable CJD. The combination of raised tau and positive 14-3-3 increased the specificity but slightly reduced the sensitivity. Statistical analysis indicated that the raised level of tau positively correlated with the presence of 14-3-3 in CSF but not with other main clinical features, eg, age, gender, clinical manifestations and sampling time.
CONCLUSIONS: These data suggest that Chinese patients with probable CJD have similar increased levels of tau in the CSF as in Caucasian patients. Measurement of CSF tau will be another potential technique for antemortem CJD diagnosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20881758     DOI: 10.1097/MAJ.0b013e3181e92a1f

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  15 in total

1.  The EEG in E200K familial CJD: relation to MRI patterns.

Authors:  Shmuel A Appel; Joab Chapman; Isak Prohovnik; Chen Hoffman; Oren S Cohen; Ilan Blatt
Journal:  J Neurol       Date:  2011-08-12       Impact factor: 4.849

2.  A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease.

Authors:  Clive Hamlin; Gianfranco Puoti; Sally Berri; Elliott Sting; Carrie Harris; Mark Cohen; Charles Spear; Alberto Bizzi; Sara M Debanne; Douglas Y Rowland
Journal:  Neurology       Date:  2012-07-25       Impact factor: 9.910

Review 3.  Interpretation of cerebrospinal fluid protein tests in the diagnosis of sporadic Creutzfeldt-Jakob disease: an evidence-based approach.

Authors:  Michael B Coulthart; Gerard H Jansen; Neil R Cashman
Journal:  CMAJ       Date:  2014-01-20       Impact factor: 8.262

4.  Remarkable increases of α1-antichymotrypsin in brain tissues of rodents during prion infection.

Authors:  Cao Chen; Xiao-Feng Xu; Ren-Qing Zhang; Yue Ma; Yan Lv; Jian-Le Li; Qiang Shi; Kang Xiao; Jing Sun; Xiao-Dong Yang; Qi Shi; Xiao-Ping Dong
Journal:  Prion       Date:  2017-09-03       Impact factor: 3.931

5.  Prion Disease Induces Alzheimer Disease-Like Neuropathologic Changes.

Authors:  Thomas Tousseyn; Krystyna Bajsarowicz; Henry Sánchez; Ania Gheyara; Abby Oehler; Michael Geschwind; Bernadette DeArmond; Stephen J DeArmond
Journal:  J Neuropathol Exp Neurol       Date:  2015-09       Impact factor: 3.685

Review 6.  Fluid biomarkers in Alzheimer's disease - current concepts.

Authors:  Christoffer Rosén; Oskar Hansson; Kaj Blennow; Henrik Zetterberg
Journal:  Mol Neurodegener       Date:  2013-06-21       Impact factor: 14.195

7.  Total-tau in cerebrospinal fluid of patients with multiple sclerosis decreases in secondary progressive stage of disease and reflects degree of brain atrophy.

Authors:  Jacek Jaworski; Marek Psujek; Marzena Janczarek; Małgorzata Szczerbo-Trojanowska; Halina Bartosik-Psujek
Journal:  Ups J Med Sci       Date:  2012-05-04       Impact factor: 2.384

8.  Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease.

Authors:  Gianluigi Zanusso; Michele Fiorini; Sergio Ferrari; Alberto Gajofatto; Annachiara Cagnin; Andrea Galassi; Silvia Richelli; Salvatore Monaco
Journal:  Int J Mol Sci       Date:  2011-09-23       Impact factor: 5.923

9.  Quantitative appraisal of ventricular cerebrospinal fluid biomarkers in neuropathologically diagnosed Parkinson's disease cases lacking Alzheimer's disease pathology.

Authors:  Chera L Maarouf; Thomas G Beach; Charles H Adler; Michael Malek-Ahmadi; Tyler A Kokjohn; Brittany N Dugger; Douglas G Walker; Holly A Shill; Sandra A Jacobson; Marwan N Sabbagh; Alex E Roher
Journal:  Biomark Insights       Date:  2013-03-12

10.  Antibody-free quantification of seven tau peptides in human CSF using targeted mass spectrometry.

Authors:  Pauline Bros; Jérôme Vialaret; Nicolas Barthelemy; Vincent Delatour; Audrey Gabelle; Sylvain Lehmann; Christophe Hirtz
Journal:  Front Neurosci       Date:  2015-09-01       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.